Form 4: CME Group Director Patrick Mulchrone Reports Future Stock Grant

CME Group Inc. Director Patrick J. Mulchrone has filed a Form 4 indicating a future acquisition of 532 shares of Class A Common Stock on June 25, 2025, as part of the company's Director Stock Plan.

Summary

• Patrick J. Mulchrone, a Director of CME Group Inc. (CME), reported a planned acquisition of 532 shares of Class A Common Stock.
• The transaction is scheduled to occur on June 25, 2025, at a price of $273.03 per share.
• This acquisition is a grant made pursuant to the CME Group Director Stock Plan, as amended and restated.
• Following this transaction, Mr. Mulchrone will directly beneficially own 28,485 shares of Class A Common Stock.
• Additionally, 25,000 shares are indirectly beneficially owned by his spouse.

Sentiment

Score: 7

Explanation: The sentiment is positive as a director's acquisition of shares, even if a grant, generally signals alignment with shareholder interests and confidence in the company's future, especially when part of a structured compensation plan.

Positives

• The acquisition of shares by a director, even if a grant, generally aligns the director's interests with those of the shareholders, promoting long-term value creation.
• The transaction is part of a pre-existing Director Stock Plan, indicating a structured approach to executive compensation and retention.

Future Outlook

This filing reports a future planned stock grant to a director, indicating ongoing compensation practices under the company's Director Stock Plan.

Industry Context

This Form 4 filing is specific to an individual director's compensation and does not directly reflect broader industry trends, though stock grants are a common form of executive and director compensation across various industries.

Stakeholder Impact

• Shareholders: The acquisition of shares by a director can be viewed positively as it aligns management's financial interests with those of the shareholders, potentially fostering a focus on long-term company performance.

Key Dates

Keywords

CME Group, Patrick J. Mulchrone, Form 4, Insider Transaction, Stock Grant, Director Compensation, Equity Acquisition, Beneficial Ownership, CME